Remove Big Data Remove Nurses Remove Trials
article thumbnail

BioXcel Therapeutics Receives FDA Clearance of IND for Phase 2 Trial with BXCL501 for the Treatment of Agitation Associated with DeliriumFifth potential indication for BXCL501, an orally dissolving thin film

The Pharma Data

The Company plans to initiate a Phase 2 trial within the next several months. “We An exploratory endpoint of this trial will be to determine the overall clinical improvement after drug administration using the Clinical Global Impression – Improvement Scale (“CGI-I”). BioXcel Therapeutics, Inc.

Trials 40
article thumbnail

October 24, 2024: APA-SM Trial Joins the NIH Pragmatic Trials Collaboratory

Rethinking Clinical Trials

The NIH Pragmatic Trials Collaboratory is pleased to welcome APA-SM (Personalized Auricular Point Acupressure for Chronic Pain Self-Management in Rural Populations) to its portfolio of innovative NIH Collaboratory Trials. Kawi is a Lee and Joseph Jamail Distinguished Professor in the Cizik School of Nursing at UTHealth Houston.

Trials 147